🔒
Price chart and 15 days of daily prices
Candlestick chart with moving averages, Bollinger bands and MACD.
Register free to view.
Security Profile
- Security Type
- Common Stock
- CUSIP
- 09203E105
- Market Cap
- Micro Cap
- IPO
- 1/30/2020 · $19.00/share
Business: Black Diamond Therapeutics, Inc. is a precision oncology medicine company pioneering the discovery of small molecule, tumor-agnostic therapies. The Company’s proprietary technology platform, Mutation-Allostery-Pharmacology, or MAP, platform, is designed to allow Black Diamond to analyze population-level genetic sequencing data to identify oncogenic mutations that promote cancer across tumor types, group these mutations into families, and develop a single small molecule therapy in a tumor-agnostic manner that targets a specific family of mutations.
Company Contact
- CEO
- Mark Velleca
- CFO
- Erika Jones
- Headquarters
- One Main Street, 14th Floort, Cambridge, MA 02142
- Phone
- 617-252-0848
- Investor Relations
- Julie Seidel · 212-362-1200 · investors@bdtx.com